EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astrocyte Reprogramming Drives Tumor Progression and Chemotherapy Resistance in Agent-Based Models of Breast Cancer Brain Metastases

Rupleen Kaur iD, Rowan Barker-Clarke, Andrew Dhawan

Bulletin of Mathematical Biology · 2025

DOI: 10.1007/s11538-025-01557-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Mathematical Biology, 2025. Verfasst von Rupleen Kaur und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Case Western Reserve University, Cleveland, OH, 44106, USA. kaurr10@ccf.org. Hauptthemen laut MEDLINE: Astrocytes, Breast Neoplasms, Brain Neoplasms, Models, Biological. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer brain metastases (BCBM) affect nearly 90,000 patients annually in the United States and carry a significant risk of mortality. As metastatic lesions develop, the unique milieu of the brain microenvironment shapes disease progression and therapeutic response. Among resident brain cells, astrocytes are both the most common, and are increasingly recognized as key regulators of this process, yet their precise role remains poorly defined. Here, we present a hybrid agent-based model (ABM) to simulate tumor–astrocyte interactions on a two-dimensional lattice. In our model, metastatic tumor cells induce phenotypic reprogramming of astrocytes from an anti- to a pro-metastatic state, thereby enhancing tumor proliferation. We systematically evaluate how variations in astrocyte density, spatial distribution, and chemotherapy impact tumor expansion and spatial morphology, quantified by fractal dimension, lacunarity, and eccentricity. Our simulations reveal that astrocyte reprogramming accelerates tumor progression and contributes to increased morphological complexity and chemotherapeutic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesBreast NeoplasmsBrain NeoplasmsModels, BiologicalHumansFemaleDrug Resistance, NeoplasmDisease ProgressionTumor MicroenvironmentMathematical ConceptsComputer SimulationCellular ReprogrammingCell Proliferation

Stichwörter der Autor:innen

Agent-Based ModelingAstrocyte–Tumor InteractionsBreast Cancer Brain MetastasesChemotherapy Resistance

Autor:innen und Institutionen

  • Department of Nutrition, Case Western Reserve University, Cleveland, OH, 44106, USA. kaurr10@ccf.org.
  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. kaurr10@ccf.org.
  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Department of Physics, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Department of Nutrition, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Cleveland Clinic Lerner College of Medicine, Cleveland, OH, 44195, USA.

ORCID-Profile: Rupleen Kaur

Förderung

  • NCATS NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • American Cancer Society
  • National Institutes of Health

Zitieren

APA

Kaur, R., Barker-Clarke, R., & Dhawan, A. (2025). Astrocyte Reprogramming Drives Tumor Progression and Chemotherapy Resistance in Agent-Based Models of Breast Cancer Brain Metastases. Bulletin of Mathematical Biology. https://doi.org/10.1007/s11538-025-01557-4

Vancouver

Kaur R, Barker-Clarke R, Dhawan A. Astrocyte Reprogramming Drives Tumor Progression and Chemotherapy Resistance in Agent-Based Models of Breast Cancer Brain Metastases. Bulletin of Mathematical Biology. 2025. doi:10.1007/s11538-025-01557-4

BibTeX
@article{Kaur2025,
  author = {Kaur, Rupleen and Barker-Clarke, Rowan and Dhawan, Andrew},
  title = {Astrocyte Reprogramming Drives Tumor Progression and Chemotherapy Resistance in Agent-Based Models of Breast Cancer Brain Metastases},
  journal = {Bulletin of Mathematical Biology},
  year = {2025},
  doi = {10.1007/s11538-025-01557-4}
}
Kostenlos starten →